Why some rheumatoid arthritis patients respond poorly to biologics

Press Release Mayo Clinic research sheds light on why some rheumatoid arthritis patients respond poorly to biologics November 14, 2016 SAN FRANCISCO — A Mayo Clinic study is shedding light on why some rheumatoid arthritis patients respond poorly when treated with tumor necrosis factor inhibitors, part of a class of drugs call biologics. It comes down to proteins: specifically, a… Click to expand…

Press Release Mayo Clinic research sheds light on why some rheumatoid arthritis patients respond poorly to biologics November 14, 2016 SAN FRANCISCO — A Mayo Clinic study is shedding light on why some rheumatoid arthritis patients respond poorly when treated with tumor necrosis factor inhibitors, part of a class of drugs call biologics. It comes down to proteins: specifically, a… Click to expand…

Link:
Why some rheumatoid arthritis patients respond poorly to biologics